Treatment with abemaciclib downregulated B7-H4 protein levels in B7-H4-OE CT26 cells in vitro (Supplementary Fig. 5b) and in tumor tissues in vivo (Supplementary Fig. 5c, d). This evidence concerns the gene VTCN1 and neoplasm.